Edition:
United Kingdom

Carl O'Donnell

FDA probes diabetes drug metformin for carcinogen NDMA

10:52am GMT

The U.S. Food and Drug Administration and other healthcare regulators are investigating whether diabetes drug metformin had contaminations of a cancer-causing chemical that prompted a recall of a commonly used heartburn medication this year.

Eli Lilly to put Loxo executives in charge of new cancer research unit

05 Dec 2019

U.S. drugmaker Eli Lilly and Co said on Thursday it will create a new cancer research division that will be run by top executives from Loxo Oncology, a cancer-focused biotech company it acquired earlier this year.

Johnson & Johnson says new tests show no asbestos in Johnson's Baby Powder

04 Dec 2019

Johnson & Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos, after U.S. Food and Drug Administration investigations reported trace amounts of the material in the product earlier this year.

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

27 Nov 2019

Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world's priciest medicines.

FOCUS-Pfizer, Novartis lead pharma spending spree on gene therapy production

27 Nov 2019

Nov 27 Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world's priciest medicines.

UPDATE 3-FDA approves Global Blood Therapeutics sickle cell disease drug

26 Nov 2019

Nov 25 The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to treat sickle cell disease in adults and children 12 years or older.

Novartis sickle-cell drug gets U.S. FDA approval

16 Nov 2019

(The Nov 16 story corrects to clarify in second graph that patients will be infused by a healthcare provider.)

World News